Clinical evaluation in adult human revealed the biosimilarity of recombinant Erythropoietin GBPD002 with Eprex®. acbr [Internet]. 2023 Aug. 1 [cited 2026 Sep. 17];7(4):459-74. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/15029